Malignant hypercalcemia revealing a diffuse large B ‐cell lymphoma in a patient with a previous diagnosis of chronic myelomonocytic leukemia: An uncommon hematological coexistence
Key Clinical MessageA 76-year-old patient previously admitted to the cardiology department for replacement of a right ventricular lead on a double-chamber pacemaker was admitted to the internal medicine department 15 days after for bronchopneumopathy. His past medical history was relevant for Type 2 diabetes mellitus, heart failure due to dilated hypokinetic heart disease, transcatheter aortic valve implantation (TAVI), and chronic myelomonocytic leukemia (CMML-0) diagnosed in 2021. Twenty-four hours after ad mission, the patient's general condition deteriorated abruptly, with the onset of drowsiness and psychomotor ret...
Source: Clinical Case Reports - September 4, 2023 Category: General Medicine Authors: Alpha Oumar Diallo,
Amelie Marcou,
J érémie Lespinasse,
Zaida Cordoba‐Sosa,
Emmanuel Andrès,
Léa Docquier,
Noel Lorenzo‐Villalba Tags: CASE REPORT Source Type: research
Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study
ConclusionsSequential TPT + ZOL therapy is likely to increase bone mineralization at the lumbar level and to stabilize it at the femoral level, similarly to what obtained with the sequential TPT+Dmab. Both ZOL and Dmab are suggested to be effective sequential treatments after TPT. (Source: Endocrine)
Source: Endocrine - August 29, 2023 Category: Endocrinology Source Type: research
Effect of a single dose of zoledronic acid on bone mineral density and trabecular bone score in Indian postmenopausal osteoporotic women with and without type 2 diabetes mellitus – A prospective cohort pilot study
ConclusionThe gain in the LS-BMD was significantly lower in T2DM group compared to non-DM subjects over 12 months after a single IV infusion of 4 mg ZA. The explanation for this could be low bone turnover in diabetes subjects at baseline. (Source: Endocrine)
Source: Endocrine - August 29, 2023 Category: Endocrinology Source Type: research
Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws in Bone Metastatic Breast and Prostate Cancer under Zoledronate Treatment: A Retrospective Analysis from 10 Years of Evaluation
CONCLUSION: Thus, increasing the attention to these patients to prevent this condition from compromising the prognosis of these individuals.PMID:37642054 | DOI:10.31557/APJCP.2023.24.8.2681 (Source: Asian Pacific Journal of Cancer Prevention)
Source: Asian Pacific Journal of Cancer Prevention - August 29, 2023 Category: Cancer & Oncology Authors: Anna Clara Arag ão Matos Carlos L ívia Moreira Caetano Coelho C ássia Emanuella Nóbrega Malta Iana Arag ão Magalhães Marcela Maria Fontes Borges Jos é Erialdo Da Silva Júnior L úcio Flávio Gonzaga Silva Paulo Goberl ânio De Barros Silva Source Type: research
